Annabel Samimy
Stock Analyst at Stifel Nicolaus
Total Price Targets
19
Stocks Covered
12
Sectors
Healthcare
Most Recent
Mar 11, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Annabel Samimy
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| KMDA | Kamada Ltd. | $11.00 | $8.17 | +34.6% | 2 | Mar 11, 2026 |
| OCS | Oculis Holding AG | $50.00 | $27.55 | +81.5% | 2 | Mar 4, 2026 |
| PHAT | Phathom Pharmaceuticals, Inc. | $28.00 | $11.73 | +138.7% | 2 | Feb 26, 2026 |
| EOLS | Evolus, Inc. | $17.00 | $5.29 | +221.7% | 1 | Jan 13, 2026 |
| SUPN | Supernus Pharmaceuticals, Inc. | $55.00 | $47.99 | +14.6% | 2 | Dec 19, 2025 |
| MBX | MBX Biosciences, Inc. Common Stock | $50.00 | $30.09 | +66.2% | 1 | Dec 19, 2025 |
| LGND | Ligand Pharmaceuticals Incorporated | $220.00 | $229.62 | -4.2% | 1 | Nov 6, 2025 |
| PVLA | Palvella Therapeutics, Inc. | $80.00 | $125.87 | -36.4% | 2 | Sep 24, 2025 |
| APLS | Apellis Pharmaceuticals, Inc. | $84.00 | $40.95 | +105.1% | 2 | Sep 20, 2024 |
| JAZZ | Jazz Pharmaceuticals plc | $230.00 | $202.38 | +13.6% | 2 | Sep 11, 2024 |
| RANI | Rani Therapeutics Holdings, Inc. | $10.00 | $0.94 | +964.1% | 1 | Jun 24, 2024 |
| RGNX | REGENXBIO Inc. | $40.00 | $9.14 | +337.6% | 1 | Jun 24, 2024 |
Recent Activity
- Mar 11, 2026— Set$11.00price target onKMDA(Kamada Ltd.)
- Mar 4, 2026— Set$50.00price target onOCS(Oculis Holding AG)
- Feb 26, 2026— Set$28.00price target onPHAT(Phathom Pharmaceuticals, Inc.)
- Jan 13, 2026— Set$17.00price target onEOLS(Evolus, Inc.)
- Dec 19, 2025— Set$55.00price target onSUPN(Supernus Pharmaceuticals, Inc.)
- Dec 19, 2025— Set$50.00price target onMBX(MBX Biosciences, Inc. Common Stock)
- Dec 19, 2025— Set$40.00price target onOCS(Oculis Holding AG)
- Nov 6, 2025— Set$220.00price target onLGND(Ligand Pharmaceuticals Incorporated)
- Sep 24, 2025— Set$80.00price target onPVLA(Palvella Therapeutics, Inc.)
- Mar 25, 2025— Set$45.00price target onPVLA(Palvella Therapeutics, Inc.)
- Nov 13, 2024— Set$20.00price target onKMDA(Kamada Ltd.)
- Sep 20, 2024— Set$84.00price target onAPLS(Apellis Pharmaceuticals, Inc.)
- Sep 11, 2024— Set$230.00price target onJAZZ(Jazz Pharmaceuticals plc)
- Jun 24, 2024— Set$40.00price target onRGNX(REGENXBIO Inc.)
- Jun 24, 2024— Set$10.00price target onRANI(Rani Therapeutics Holdings, Inc.)
- May 2, 2024— Set$24.00price target onPHAT(Phathom Pharmaceuticals, Inc.)
- Apr 8, 2024— Set$38.00price target onSUPN(Supernus Pharmaceuticals, Inc.)
- Jun 23, 2022— Set$60.00price target onAPLS(Apellis Pharmaceuticals, Inc.)
- Jan 14, 2022— Set$210.00price target onJAZZ(Jazz Pharmaceuticals plc)
Frequently Asked Questions
Who is Annabel Samimy?
Annabel Samimy is a stock analyst at Stifel Nicolaus covering 12 stocks primarily in Healthcare. They have issued 19 price targets since Jan 14, 2022.
What stocks does Annabel Samimy cover?
Annabel Samimy currently covers 12 stocks, including KMDA, OCS, PHAT, SUPN, PVLA.
What is Annabel Samimy's latest price target?
Annabel Samimy's most recent price target was $11.00 on KMDA (Kamada Ltd.), set on Mar 11, 2026.
What is Annabel Samimy's highest price target?
Annabel Samimy's highest issued price target is $230.00 on JAZZ, set on Sep 11, 2024.
More Analysts at Stifel Nicolaus
Coverage based on publicly published price targets. Not investment advice.